Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies.

PubWeight™: 5.85‹?› | Rank: Top 1%

🔗 View Article (PMC 347909)

Published in Infect Immun on January 01, 1983

Authors

H Greenberg, V McAuliffe, J Valdesuso, R Wyatt, J Flores, A Kalica, Y Hoshino, N Singh

Articles citing this

(truncated to the top 100)

Rotavirus gene structure and function. Microbiol Rev (1989) 6.95

Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94

Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44

Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88

The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23

Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73

Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol (1987) 3.58

Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol (1994) 3.50

Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol (1985) 3.23

Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17

Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J Virol (1985) 2.81

Human viral gastroenteritis. Microbiol Rev (1984) 2.70

Isolation and serotyping of porcine rotaviruses and antigenic comparison with other rotaviruses. J Clin Microbiol (1984) 2.65

Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol (1985) 2.47

Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol (1999) 2.31

Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. J Virol (1987) 2.29

Rotavirus serotype G5 associated with diarrhea in Brazilian children. J Clin Microbiol (1994) 2.28

Molecular characterization of VP6 genes of human rotavirus isolates: correlation of genogroups with subgroups and evidence of independent segregation. J Virol (2002) 2.27

Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16

Receptor activity of rotavirus nonstructural glycoprotein NS28. J Virol (1989) 2.09

Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol (2001) 2.06

Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus. J Clin Microbiol (1983) 1.91

Cultivation and characterization of three strains of murine rotavirus. J Virol (1986) 1.90

Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol (1990) 1.85

Infectious diarrhea of infant rats produced by a rotavirus-like agent. J Virol (1984) 1.84

The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80

Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol (2001) 1.68

Genetic analysis of a human rotavirus that belongs to subgroup I but has an RNA pattern typical of subgroup II human rotaviruses. J Clin Microbiol (1987) 1.65

Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses. J Clin Invest (1987) 1.61

Cultivation and characterization of human rotaviruses with "super short" RNA patterns. J Clin Microbiol (1987) 1.58

Detection of rotavirus in human stools by using monoclonal antibody. J Clin Microbiol (1984) 1.56

Subgroups, serotypes, and electrophoretypes of rotavirus isolated from children in Bangui, Central African Republic. J Clin Microbiol (1988) 1.54

RNA-RNA hybridization identifies a human rotavirus that is genetically related to feline rotavirus. J Virol (1989) 1.53

Some infectious causes of diarrhea in young farm animals. Clin Microbiol Rev (1990) 1.51

Induction of cross-reactive serum neutralizing antibody to human rotavirus in calves after in utero administration of bovine rotavirus. J Clin Microbiol (1983) 1.49

Cloning and nucleotide sequence of the simian rotavirus gene 6 that codes for the major inner capsid protein. Nucleic Acids Res (1984) 1.48

Surveillance of rotavirus strains in the United States: identification of unusual strains. The National Rotavirus Strain Surveillance System collaborating laboratories. J Clin Microbiol (2000) 1.47

Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J Clin Microbiol (1993) 1.46

Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol (2004) 1.41

Molecular and antigenic characterization of porcine rotavirus YM, a possible new rotavirus serotype. J Virol (1988) 1.38

Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol (1990) 1.37

Great diversity of group A rotavirus strains and high prevalence of mixed rotavirus infections in India. J Clin Microbiol (2001) 1.36

Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol (1993) 1.36

New porcine rotavirus serotype antigenically related to human rotavirus serotype 3. J Clin Microbiol (1988) 1.35

Molecular identification by RNA-RNA hybridization of a human rotavirus that is closely related to rotaviruses of feline and canine origin. J Clin Microbiol (1990) 1.34

Epidemiological survey of human rotavirus serotypes and electropherotypes in young children admitted to two children's hospitals in northeast London from 1984 to 1990. J Clin Microbiol (1991) 1.34

Relative frequency of rotavirus subgroups 1 and 2 in Venezuelan children with gastroenteritis as assayed with monoclonal antibodies. J Clin Microbiol (1984) 1.32

Changing patterns of rotavirus genotypes in ghana: emergence of human rotavirus G9 as a major cause of diarrhea in children. J Clin Microbiol (2003) 1.23

Molecular epidemiology of human rotaviruses. Analysis of outbreaks of acute gastroenteritis in Glasgow and the west of Scotland 1981/82 and 1982/83. J Hyg (Lond) (1984) 1.22

Clinical and epidemiological features of acute infantile gastroenteritis associated with human rotavirus subgroups 1 and 2. J Clin Microbiol (1986) 1.21

Human viral gastroenteritis. Clin Microbiol Rev (1989) 1.21

Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20

Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype. J Virol (2005) 1.15

Isolation, propagation, and characterization of a second equine rotavirus serotype. Infect Immun (1983) 1.15

Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses. J Virol (1992) 1.15

Comparative sequence analysis of rotavirus genomic segment 6--the gene specifying viral subgroups 1 and 2. J Virol (1984) 1.14

Role of the inner protein capsid on in vitro human rotavirus transcription. J Virol (1986) 1.14

Antigenic characterization of swine rotaviruses in Argentina. J Clin Microbiol (1989) 1.13

Serological comparison of canine rotavirus with various simian and human rotaviruses by plaque reduction neutralization and hemagglutination inhibition tests. Infect Immun (1983) 1.11

Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. J Clin Microbiol (1996) 1.10

Isolation and characterization of an equine rotavirus. J Clin Microbiol (1983) 1.07

Similarity of the outer capsid protein VP4 of the Gottfried strain of porcine rotavirus to that of asymptomatic human rotavirus strains. J Virol (1990) 1.07

Molecular epidemiology and subgroup determination of bovine group A rotaviruses associated with diarrhea in dairy and beef calves. J Clin Microbiol (1989) 1.03

Isolation of an avianlike group A rotavirus from a calf with diarrhea. J Clin Microbiol (1992) 1.03

Retracted Diversity in Indian equine rotaviruses: identification of genotype G10,P6[1] and G1 strains and a new VP7 genotype (G16) strain in specimens from diarrheic foals in India. J Clin Microbiol (2006) 1.02

Intracellular manipulation of disulfide bond formation in rotavirus proteins during assembly. J Virol (1994) 1.02

Dissecting rotavirus particle-raft interaction with small interfering RNAs: insights into rotavirus transit through the secretory pathway. J Virol (2006) 1.01

The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol (2004) 1.01

Detection of human rotaviruses which do not react with subgroup I- and II-specific monoclonal antibodies. J Clin Microbiol (1988) 1.00

Serotype 3 human rotavirus strains with subgroup I specificity. J Clin Microbiol (1990) 0.99

Distribution of rotavirus VP7 serotypes and VP4 genotypes circulating in Sousse, Tunisia, from 1995 to 1999: emergence of natural human reassortants. J Clin Microbiol (2000) 0.99

Monoclonal antibodies to subgroup 1 rotavirus. Infect Immun (1983) 0.98

Predominance of rotavirus genotype G9 during the 1999, 2000, and 2002 seasons among hospitalized children in the city of Salvador, Bahia, Brazil: implications for future vaccine strategies. J Clin Microbiol (2005) 0.98

Serotypic differentiation of group A rotaviruses with porcine rotavirus gene 9 probes. J Clin Microbiol (1990) 0.96

Simian rotaviruses possess divergent gene constellations that originated from interspecies transmission and reassortment. J Virol (2009) 0.96

Monoclonal antibodies directed against different antigenic determinants of rotavirus. J Virol (1984) 0.96

Serological characterization of human reassortant rotaviruses. J Virol (1986) 0.94

Hemagglutination by a human rotavirus isolate as evidence for transmission of animal rotaviruses to humans. J Clin Microbiol (1992) 0.94

Partial characterization of a bovine group A rotavirus with a short genome electropherotype. J Clin Microbiol (1988) 0.94

Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts. J Virol (2007) 0.92

1998-1999 rotavirus seasons in Juiz de Fora, Minas Gerais, Brazil: detection of an unusual G3P[4] epidemic strain. J Clin Microbiol (2002) 0.92

Detection of an unusual human rotavirus strain with G5P[8] specificity in a Cameroonian child with diarrhea. J Clin Microbiol (2004) 0.90

Lack of cosegregation of the subgroup II antigens on genes 2 and 6 in porcine rotaviruses. J Virol (1990) 0.90

Eight-year survey of human rotavirus strains demonstrates circulation of unusual G and P types in Hungary. J Clin Microbiol (2004) 0.90

Rotavirus serotype G3 predominates in horses. J Clin Microbiol (1992) 0.90

Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol (1991) 0.90

In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PLoS One (2012) 0.89

Epitopes of Escherichia coli alpha-hemolysin: identification of monoclonal antibodies that prevent hemolysis. Infect Immun (1990) 0.89

Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus. J Clin Microbiol (1990) 0.89

Heterologous protection against rotavirus-induced disease in gnotobiotic piglets. J Clin Microbiol (1986) 0.88

Novel light-upon-extension real-time PCR assay for simultaneous detection, quantification, and genogrouping of group A rotavirus. J Clin Microbiol (2010) 0.88

Cultivation and subgroup determination of human rotaviruses from Egyptian infants and young children. J Clin Microbiol (1984) 0.87

Evidence for two serotype G3 subtypes among equine rotaviruses. J Clin Microbiol (1992) 0.86

Neutralizing monoclonal antibodies against three serotypes of porcine rotavirus. J Virol (1989) 0.86

Molecular characterization of a subgroup specificity associated with the rotavirus inner capsid protein VP2. J Virol (2008) 0.86

Typing of cytopathic and noncytopathic bovine viral diarrhea virus reference and Canadian field strains using a neutralizing monoclonal antibody. Can J Vet Res (1988) 0.86

Identification of feline- and canine-like rotaviruses isolated from humans by restriction fragment length polymorphism assay. J Clin Microbiol (1993) 0.86

Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus. J Clin Microbiol (1992) 0.84

Equine rotaviruses with G14 serotype specificity circulate among venezuelan horses. J Clin Microbiol (1994) 0.84

Distinct serotypes of porcine rotavirus associated with diarrhea in suckling piglets in southern Quebec. Can J Vet Res (1986) 0.83

Articles cited by this

Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94

Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22

Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19

Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73

Morphological and antigenic relationships between viruses (rotaviruses) from acute gastroenteritis of children, calves, piglets, mice, and foals. Infect Immun (1976) 4.55

Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47

In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40

Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA. Virology (1978) 4.08

Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83

Rotavirus serotypes by serum neutralisation. J Med Virol (1980) 3.65

Preparation and characterization of antisera to electrophoretically purified SA11 virus polypeptides. Infect Immun (1981) 3.59

Selective and reversible inhibition of initiation of protein synthesis in mammalian cells. J Mol Biol (1974) 3.41

Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23

Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13

Coding assignments of double-stranded RNA segments of SA 11 rotavirus established by in vitro translation. J Virol (1980) 3.10

Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97

Microtiter solid-phase radioimmunoassay for hepatitis B antigen. Appl Microbiol (1973) 2.96

Antigenic relationships among five reovirus-like (RVL) agents by complement fixation (CF) and development of new substitute CF antigens for the human RVL agent of infantile gastroenteritis. Proc Soc Exp Biol Med (1976) 2.74

Neonatal calf diarrhoea: identification of a reovirus-like (rotavirus) agent in faeces by immunofluorescence and immune electron microscopy. Br Vet J (1976) 2.61

Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis (1980) 2.39

Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol (1980) 2.39

Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines. Virology (1981) 2.36

Enzyme-linked immunosorbent assay for identification of rotaviruses from different animal species. Science (1978) 2.36

The molecular biology of rotaviruses. II. Identification of the protein-coding assignments of calf rotavirus genome RNA species. Virology (1982) 2.34

Isolation and characterization of a canine rotavirus. Arch Virol (1982) 2.26

In vitro transcription of two human rotaviruses. J Virol (1982) 1.88

Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol (1982) 1.65

Rotavirus infection in avian species. Vet Rec (1978) 1.13

Articles by these authors

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature (1998) 24.69

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (1996) 11.37

A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet (1997) 10.93

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science (1998) 8.36

Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol (1992) 8.25

Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16

Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94

Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science (1997) 6.00

Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure (2000) 5.57

Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44

Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19

Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13

Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell (1999) 4.97

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96

Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88

Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54

Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A (2000) 4.44

Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25

Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13

Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06

Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80

Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res (1998) 3.71

Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol (1987) 3.58

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol (2000) 3.52

Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J Virol (1997) 3.46

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol (1994) 3.43

The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med (2001) 3.39

Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23

Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. Virology (1987) 3.22

Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13

An extremely luminous panchromatic outburst from the nucleus of a distant galaxy. Science (2011) 3.09

Comparison of health status and quality of life of related versus paid unrelated living kidney donors. Am J Transplant (2013) 3.04

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J Virol (2000) 2.97

Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97

Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95

Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins. J Virol (2000) 2.86

Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1). J Biol Chem (1999) 2.85

Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. Chest (1999) 2.58

Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J Virol (2006) 2.57

Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet (2000) 2.53

The natural history of dysphagia following a stroke. Dysphagia (1997) 2.51

Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol (1985) 2.47

Effects of age on brain volume and head circumference in autism. Neurology (2002) 2.44

Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J Virol (1988) 2.44

FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol (1998) 2.43

Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol (1986) 2.42

Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet (1999) 2.42

Evidence for extraterrestrial amino-acids and hydrocarbons in the Murchison meteorite. Nature (1970) 2.41

A milling crowd model for local and long-range obstructed lateral diffusion. Mobility of excimeric probes in the membrane of intact erythrocytes. Biophys J (1986) 2.39

Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol (1988) 2.38

Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. J Virol (2001) 2.38

The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest (1972) 2.38

Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. Proc Natl Acad Sci U S A (1986) 2.37

Rational modifications of HIV-1 envelope glycoproteins for immunogen design. Curr Pharm Des (2007) 2.35

Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis (1992) 2.29

Rotavirus serotype G5 associated with diarrhea in Brazilian children. J Clin Microbiol (1994) 2.28

A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J Virol (1998) 2.28

Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination. Infect Immun (1976) 2.27

Isolation and characterization of a canine rotavirus. Arch Virol (1982) 2.26

Nucleotide sequence of the structural glycoprotein VP7 gene of Nebraska calf diarrhea virus rotavirus: comparison with homologous genes from four strains of human and animal rotaviruses. Virology (1985) 2.23

Unreliability of Rotazyme ELISA test in neonates. J Pediatr (1983) 2.16

Adhesions of the labia minora. A study of 50 patients. Obstet Gynecol (1972) 2.15

Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution. J Virol (2000) 2.15

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect (2014) 2.13

The membrane of peroxisomes in Saccharomyces cerevisiae is impermeable to NAD(H) and acetyl-CoA under in vivo conditions. EMBO J (1995) 2.12

Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization. J Clin Microbiol (2002) 2.12

Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J Virol (1988) 2.12

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood (2001) 2.05

Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis (1979) 2.05

Isolation and characterization of two distinct human rotavirus strains with G6 specificity. J Clin Microbiol (1992) 2.03

Intensive care services; a crisis of increasing expressed demand. Anaesthesia (1998) 2.02

Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes. Virology (1989) 1.99

Management of giant anal condyloma by wide local excision and anoplasty. Colorectal Dis (2012) 1.99

Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. J Infect Dis (1986) 1.95

Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot (Tokyo) (1994) 1.93

Molecular characterization of Hawaii virus and other Norwalk-like viruses: evidence for genetic polymorphism among human caliciviruses. J Infect Dis (1994) 1.92

Chiral symmetry breaking in sodium chlorate crystallizaton. Science (1990) 1.92

T-cell control of IL-12p75 production. Scand J Immunol (2006) 1.92

Anti-stress activity of Ocimum sanctum Linn. Indian J Med Res (1981) 1.91

Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis (2001) 1.91

Asynchronous replication and allelic exclusion in the immune system. Nature (2001) 1.89

VP7 serotype-specific glycoprotein of OSU porcine rotavirus: coding assignment and gene sequence. J Gen Virol (1986) 1.88

In vitro transcription of two human rotaviruses. J Virol (1982) 1.88

CD4-independent binding of SIV gp120 to rhesus CCR5. Science (1997) 1.87